New way to overcome colorectal cancer’s resistance to immune response
Immune checkpoint inhibitors, which unleash the immune response against tumor cells, have revolutionized cancer treatment; however, the medications aren’t effective in a large number of patients, including those with colorectal cancer. Now, new research led by investigators at Harvard-affiliated Massachusetts General Hospital and the University of Geneva and published in PNAS provides insights on why… Read More »